MULTIPLE MYLEOMA

Clinical trials for MULTIPLE MYLEOMA explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYLEOMA trials appear

Sign up with your email to follow new studies for MULTIPLE MYLEOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for blood cancer patients: drug aims to slash infection risk

Disease control Recruiting now

This study tests whether a medicine called XEMBIFY, given every two weeks alongside standard care, can reduce serious bacterial infections in adults with certain blood cancers (chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma) who also have low antibody lev…

Matched conditions: MULTIPLE MYLEOMA

Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control

Last updated Jun 27, 2026 12:06 UTC

MULTIPLE MYLEOMA

Get alerted when new MULTIPLE MYLEOMA trials appear

New hope for blood cancer patients: drug aims to slash infection risk